WHO urges Ebola vaccine trials
The World Health Organization has recommended conducting a large-scale clinical trial of the only approved Ebola vaccine, "Ervebo," in the Democratic Republic of the Congo. This is to verify its effectiveness against the currently circulating strain, "Bondipogyo." Studies have shown that the vaccine provides good protection against the most common strain. The recommendation focuses on testing it in the context of an outbreak where the number of confirmed cases has reached 4,053, including 1,850 deaths, with the disease spreading at a faster rate than control efforts can contain. The organization affirms the safety of the vaccine and advises its use to reduce mortality and improve the response to the outbreak.
Notice: This Is an AI-Generated Summary
Comments (0)